Investment analysts at Leerink Partnrs dropped their Q2 2025 earnings per share (EPS) estimates for shares of Quest ...
Valued at a market cap of $18.2 billion, Quest Diagnostics Incorporated (DGX) provides diagnostic testing and services in the ...
Redburn Atlantic began coverage on shares of Quest Diagnostics (NYSE:DGX – Free Report) in a report issued on Wednesday morning, MarketBeat reports. The firm issued a buy rating and a $195.00 price ...
Shares of Quest Diagnostics Inc. DGX slid 3.78% to $164.18 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 5.97% to 5,074.08 ...
Quest Diagnostics Inc. closed 4.61% short of its 52-week high of $178.87, which the company reached on March 10th.
Fintel reports that on April 2, 2025, Redburn Atlantic initiated coverage of Quest Diagnostics (NYSE:DGX) with a Buy ...
Redburn Atlantic analyst Jamie Clark initiated coverage of Quest Diagnostics (DGX) with a Buy rating and $195 price target Don't Miss Our End ...